Curriculum Vitae
In 1997 she graduated in Biology at the University of Santiago de Compostela (Spain). She also obtained a Masters Degree in Physiology and Biophysics at the Univ. Illinois at Chicago (2004) and a Ph.D. in Neuroscience at the University of Milano-Bicocca in 2007. Currently she works as Laboratory Technician specialized in histology and microscopy techniques such as immunohistochemistry, electron microscopy and confocal microscopy.
RESEARCH INTERESTS
- Neuroprotection in chemotherapy induced peripheral neuropathies (CIPN).
- Epigenetic mechanisms and alterations on neurodegenerative diseases and CIPN.
MOST RELEVANT PUBLICATIONS
- Monfrini M, Donzelli E, Rodriguez-Menendez V, Ballarini E, Carozzi VA, Chiorazzi A, Meregalli C, Canta A, Oggioni N, Crippa L, Avezza F, Silvani S, Bonandrini B, Figliuzzi M, Remuzzi A, Porretta-Serapiglia C, Bianchi R, Lauria G, Tredici G, Cavaletti G, Scuteri A. Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy. Exp Neurol. 2017 Feb;288:75-84.
- Canta A, Chiorazzi A, Carozzi VA, Meregalli C, Oggioni N, Bossi M, Rodriguez-Menendez V, Avezza F, Crippa L, Lombardi R, de Vito G, Piazza V, Cavaletti G, Marmiroli P. Age-related changes in the function and structure of the peripheral sensory pathway in mice. Neurobiol Aging. 2016 Sep;45:136-148. doi: 10.1016/j.neurobiolaging.2016.05.014.
- Meregalli C, Carozzi VA, Sala B, Chiorazzi A, Canta A, Oggioni N, Rodriguez-Menendez V, Ballarini E, Ceresa C, Nicolini G, Crippa L, Orciani M, Cavaletti G, Marmiroli P. Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice. J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):115-24.
- Scuteri A, Donzelli E, Rodriguez-Menendez V, Ravasi M, Monfrini M, Bonandrini B, Figliuzzi M, Remuzzi A, Tredici G. A double mechanism for the mesenchymal stem cells’ positive effect on pancreatic islets. PLoS One. 2014 Jan 8;9(1):e84309.
- Tremolizzo L, Rodriguez-Menendez V, Conti E, Zoia CP, Cavaletti G, Ferrarese C. Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome. Curr Pharm Des. 2014;20(11):1831-9. Review.
Find out more on SCOPUS